超声筛查中重度银屑病患者亚临床银屑病关节炎的作用
研究纳入490例中重度银屑病患者及80例非银屑病对照,对60个关节、38条肌腱和40个附着点行超声检查。仅滑膜-附着点炎在对照组与无症状银屑病组间差异显著(1.3% vs. 16.1%,p<0.001),以滑膜-附着点炎为标准,12.7%的中重度银屑病患者处于亚临床PsA期。结论推荐无论有无关节炎症状,常规超声筛查滑膜-附着点炎,尤其下肢。
要点
- 超声检测的滑膜-附着点炎是筛查亚临床PsA的关键征象,膝关节最常受累(79.0%)。
- 中重度银屑病患者中亚临床PsA比例高达12.7%,无论有无关节炎症状均应常规筛查。
- BSA和PASI评分在银屑病单纯、亚临床PsA及前驱/活动性PsA三期之间无差异。
关键影像表现/征象
- 仅滑膜-附着点炎在对照组与沉默银屑病组间差异显著(1.3% vs. 16.1%,p<0.001)。
- 膝关节是滑膜-附着点炎最常受累部位,占79.0%。
诊断标准与关键数值
- 以超声检测的滑膜-附着点炎为标准,16.1%的沉默银屑病患者和12.7%的全部银屑病患者处于亚临床PsA期。
临床应用与阅片要点
- 对中重度银屑病患者应常规行超声评估滑膜-附着点炎以筛查亚临床PsA,尤其注意下肢关节。
- 不应仅凭BSA和PASI评分判断是否需要筛查,因三期之间无差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To identify patients in the subclinical psoriatic arthritis (Sub-PsA) phase by ultrasound (US) and provide a solution to screen them.
METHODS: A total of 490 participants with moderate-to-severe psoriasis were evaluated. Among them, 384 participants without arthritis symptoms were enrolled into the silent psoriasis group and 106 participants with arthritis symptoms, called prodromal/active PsA phase, were enrolled into the clinical PsA group. Another 80 non-psoriasis participants were enrolled into the control group. Each participant received clinical assessments and US examinations of 60 joints, 38 tendons, and 40 entheses. We compared the incidences of synovio-enthesitis, synovitis, tenosynovitis, erosion, and dactylitis detected on US among the three groups. Subsequently, on the basis of significant US findings, we distinguished Sub-PsA from psoriasis alone (PsO) in the silent psoriasis group and analyzed the clinical characteristics, mainly including basic clinical characteristics, body surface area (BSA), and Psoriasis Area and Severity Index (PASI) score.
RESULTS: Only synovio-enthesitis significantly differed between the control group and the silent psoriasis group (1.3% vs. 16.1%, p < 0.001). The knee was the most commonly involved site of synovio-enthesitis (79.0%). Taking synovio-enthesitis as the standard, 16.1% of silent psoriasis participants and 12.7% of all psoriasis participants were in the Sub-PsA phase. Furthermore, there were no differences in BSA and PASI among the three phases of PsO, Sub-PsA, and prodromal/active PsA.
CONCLUSIONS: Since the psoriasis patients in Sub-PsA phase was as high as 12.7% in all patients with moderate-to-severe psoriasis, US-detected synovio-enthesitis was recommended routinely for screening them regardless of arthritis symptoms, especially in the lower limbs.
KEY POINTS: • Synovio-enthesitis on ultrasound was significantly associated with subclinical psoriatic arthritis, especially in the lower limbs. • Routine ultrasound evaluation could help screen psoriasis patients in the subclinical psoriatic arthritis phase, which was as high as 12.7% in all psoriasis patients.
引用
- Chen, Chen, Li, et al. The role of ultrasound in screening subclinical psoriatic arthritis in patients with moderate to severe psoriasis. Eur Radiol. 2023. PMID: 36853346. doi:10.1007/s00330-023-09493-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。